Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CO2 Inhalation as a New Treatment Modality for Apnea of Prematurity

NCT01066728 is registered in ClinicalTrials.gov with University of Manitoba as lead sponsor.

NCT NCT01066728
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01066728 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CO2 Inhalation as a New Treatment Modality for Apnea of Prematurity
Lead sponsor
University of Manitoba
Phase
Phase 2/3
Overall status
Completed
Start date
August 31, 2001
Completion date
March 31, 2007
Enrollment
87 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

apnea of prematurity